Benefit of low-dose tamoxifen in a large observational cohort of high risk ER positive breast DCIS
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Benefit of low-dose tamoxifen in a large observational cohort of high risk ER positive breast DCIS
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 139, Issue 9, Pages 2127-2134
Publisher
Wiley
Online
2016-07-06
DOI
10.1002/ijc.30254
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial
- (2016) John F Forbes et al. LANCET
- Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial
- (2016) Richard G Margolese et al. LANCET
- Addressing overtreatment of screen detected DCIS; the LORIS trial
- (2015) Adele Francis et al. EUROPEAN JOURNAL OF CANCER
- RTOG 9804: A Prospective Randomized Trial for Good-Risk Ductal Carcinoma In Situ Comparing Radiotherapy With Observation
- (2015) Beryl McCormick et al. JOURNAL OF CLINICAL ONCOLOGY
- Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ
- (2015) Mathias Worni et al. JNCI-Journal of the National Cancer Institute
- Risk of second non-breast cancer after radiotherapy for breast cancer: A systematic review and meta-analysis of 762,468 patients
- (2015) Trine Grantzau et al. RADIOTHERAPY AND ONCOLOGY
- Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ
- (2015) Mathias Worni et al. JNCI-Journal of the National Cancer Institute
- Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ
- (2015) Steven A. Narod et al. JAMA Oncology
- Lifestyle Factors and the Risk of a Second Breast Cancer after Ductal Carcinoma In Situ
- (2014) V. H. McLaughlin et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Effect of Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma in Situ: 20 Years Follow-Up in the Randomized SweDCIS Trial
- (2014) Fredrik Wärnberg et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase-III prevention trial of low-dose tamoxifen in postmenopausal hormone replacement therapy users: the HOT study
- (2013) A. DeCensi et al. ANNALS OF ONCOLOGY
- Circulating hormones and breast cancer risk in premenopausal women: a randomized trial of low-dose tamoxifen and fenretinide
- (2013) Harriet Johansson et al. BREAST CANCER RESEARCH AND TREATMENT
- Tailoring treatment for ductal intraepithelial neoplasia of the breast according to Ki-67 and molecular phenotype
- (2013) M Lazzeroni et al. BRITISH JOURNAL OF CANCER
- Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
- (2013) Sarah C. Darby et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biology, Treatment, and Outcome in Very Young and Older Women with DCIS
- (2012) Rosalinda Alvarado et al. ANNALS OF SURGICAL ONCOLOGY
- HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ
- (2012) E Rakovitch et al. BRITISH JOURNAL OF CANCER
- Abstract A56: Randomized, placebo-controlled, phase III trial of low-dose tamoxifen in women with intraepithelial neoplasia
- (2012) S. Zanardi et al. Cancer Prevention Research
- Obesity and the Risk for Premenopausal and Postmenopausal Breast Cancer
- (2012) G. L. Anderson et al. Cancer Prevention Research
- Selecting Individualized Treatment for Patients With Ductal Carcinoma in Situ of the Breast: The Search Continues
- (2012) Lawrence J. Solin JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Tamoxifen Reduces Subsequent Breast Cancer in Women With Estrogen Receptor–Positive Ductal Carcinoma in Situ: A Study Based on NSABP Protocol B-24
- (2012) D. Craig Allred et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCIS
- (2011) I. L. Wapnir et al. JNCI-Journal of the National Cancer Institute
- Ductal Carcinoma In Situ of the Breast: Influence of Age on Diagnostic, Therapeutic, and Prognostic Features. Retrospective Study of 812 Patients
- (2010) Christine Tunon-de-Lara et al. ANNALS OF SURGICAL ONCOLOGY
- National Institutes of Health State-of-the-Science Conference Statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22-24, 2009
- (2010) C. J. Allegra et al. JNCI-Journal of the National Cancer Institute
- Biomarker Expression and Risk of Subsequent Tumors After Initial Ductal Carcinoma In Situ Diagnosis
- (2010) K. Kerlikowske et al. JNCI-Journal of the National Cancer Institute
- Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial
- (2010) Jack Cuzick et al. LANCET ONCOLOGY
- Randomized Biomarker Trial of Anastrozole or Low-Dose Tamoxifen or Their Combination in Subjects with Breast Intraepithelial Neoplasia
- (2009) B. Bonanni et al. CLINICAL CANCER RESEARCH
- Randomized Double-Blind 2 × 2 Trial of Low-Dose Tamoxifen and Fenretinide for Breast Cancer Prevention in High-Risk Premenopausal Women
- (2009) Andrea Decensi et al. JOURNAL OF CLINICAL ONCOLOGY
- Radiothérapie des carcinomes canalaires in situ : impact du complément d’irradiation du lit tumoral
- (2008) D. Azria et al. Cancer Radiotherapie
- Recent advances and current controversies in the management of DCIS of the breast
- (2008) George H. Sakorafas et al. CANCER TREATMENT REVIEWS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started